SHRI SANTOSH BAGRODIA (CONTD.): The Prevention of Cruelty Against Animals Act, 1960 bans indiscriminate use of this hormone in animals. The indiscriminate use, sometimes twice a day, of this is extremely painful for the animals -- we are also concerned for the animals, Sir -- and has hazardous results for humans too who consume this milk. That is why it is connected with this subject.
MR. DEPUTY CHAIRMAN: It is a well-researched question.
SHRI SANTOSH BAGRODIA: Yet, the NDRI, which is Central Government facility has been using this hormone with impunity. Similar cases of use of Oxytocin were reported from other diaries in the country too. What steps has the Government taken in this respect? Sir, there are many more questions which can be raised. But, I would not like to raise because after discussing other subjects for four and a half hours, I know I should stick to half-an-Hour discussion only. And, he is getting very upset about it. And, I don't want to have enmity with my friend, hon. Minister. He has told me to finish it today. So, let's finish it. Thank you very much. (Ends)
MR. DEPUTY CHAIRMAN: There are no more supplementary questions. You have exhausted.
SHRI SANTOSH BAGRODIA: All right, let him reply.
ÁÖß ˆ¯ÖÃÖ³ÖÖ¯Ö×ŸÖ : †Ö¯Ö®Öê ®ÖÖê×™üÃÖ ®ÖÆüà ×¤üµÖÖ Æîü… Normally, in a half an hour Discussion, they have to give a notice earlier. †ÝÖ¸ü ‹Ûú Æüß ÃÖ¾ÖÖ»Ö Æîü, ŸÖÖê ¯Öæ×”û‹…
ÁÖß ÁÖßÝÖÖê¯ÖÖ»Ö ¾µÖÖÃÖü (”û¢ÖßÃÖÝÖœÍü) : ‡ÃÖ ×¾ÖÂÖµÖ ÛúÖê ˆšüÖ®Öê Ûêú ×»Ö‹ ²ÖÆãüŸÖ-²ÖÆãüŸÖ ¬Ö®µÖ¾ÖÖ¤ü…
´ÖÖ®Ö®ÖßµÖ ˆ¯ÖÃÖ³ÖÖ¯Ö×ŸÖ •Öß, ´Öï †Ö¯ÖÛúß †®Öã´Ö×ŸÖ ÃÖê ´ÖÖ®Ö®ÖßµÖ ´ÖÓ¡Öß •Öß ÃÖê µÖÆü •ÖÖ®Ö®ÖÖ “ÖÖÆüŸÖÖ ÆæÑü ×Ûú †Ö•ÖÛú»Ö ‡ÃÖ ¤êü¿Ö ´Öë ²ÖÆãüŸÖ ¯ÖÏÛúÖ¸ü Ûúß •Ö›Íüß-²Öæ×™üµÖÖë ÃÖê ¤ü¾ÖÖ‹Ñ ²Ö®Ö ¸üÆüß Æïü ŸÖ£ÖÖ ‡ÃÖÛêú ÃÖÖ£Ö-Æüß-ÃÖÖ£Ö µÖÖêÝÖ †Öî¸ü Ûú‡Ô ¯ÖÏµÖÖêÝÖ ³Öß ÆüÖê ¸üÆêü Æïü… ŒµÖÖ ‹êÃÖß ¤ü¾ÖÖ‹Ñ, •ÖÖê ×¾ÖÀ¾Ö ´Öë †®µÖ¡Ö ¯ÖÏ×ŸÖ²Ö×®¬ÖŸÖ Æïü, ˆ®ÖÃÖê ²Ö“Ö®Öê Ûêú ×»Ö‹ ÃÖ¸üÛúÖ¸ü, ‡ÃÖ ¯ÖÏÛúÖ¸ü Ûêú •ÖÖê ³ÖÖ¸üŸÖ ´Öë ¯ÖÏµÖÖêÝÖ ÆüÖê ¸üÆêü Æïü, ˆ®ÖÛúÖ ³Öß ×¾Ö“ÖÖ¸ü Ûú¸êüÝÖß? (ÃÖ´ÖÖ¯ŸÖ)
THE MINISTER OF HEALTH AND FAMILY WELFARE (DR. ANBUMANI RAMDOSS): Sir, thank you, for giving me an opportunity to answer to the questions raised by the hon. Members, especially, my good friend, Mr. Santosh Bagrodia. I see his fascination and obsession for the subject of globally banned drugs. In fact, I think, this is the fourth time when I am replying to this question of globally banned drugs. Like I have already answered a number of times on this subject, the concept of globally banned drugs, in fact, is a misnomer. This concept of globally banned drugs was raised by the media. There is no such thing as globally banned drugs. Drugs could be banned in the individual country. Every individual country has the capacity to ban a drug, depending upon the quality. They have their own committees, their own experts, their own advisory boards. Like I have said earlier also, the drugs which are used in the USA, could be banned in the UK or Europe and vice-versa. And, this is a method prevailing globally. Each country has its own individuality. In fact, the Committee about which my good friend, Mr. Bagrodia, has been saying, was constituted in 2001-02 under DGHS, and along with the Members of Parliament, this Committee went exhaustively into the issue of globally banned drugs and other issues of adverse drug reactions. They had consulted a complete group of specialists. They went all around the country and they had given an exhaustive report about what the Government should do in the future to avoid these issues and how the Government should strengthen its mechanism and build up infrastructure to counter these issues. Some of the drugs were taken up to the Committee also and they had given their views. I can give my good friend, Mr. Bagrodia, the complete report that the Committee had given. The Committee has also said that the Government should strengthen its vigilance committee. In fact, in 2004, with the help of the World Bank, a Pharmaco Vigilance Committee was formed. This was a high-level body consisting of experts and also linking throughout the country. We were planning to link up all the medical colleges in this country, but we could link only 30 of such colleges. This Committee is meeting every month. (Contd. by YSR-4r)
DR. ANBUMANI RAMDOSS (CONTD.): We have given them a couple of drugs of current interest. The issues of these drugs are being raked up by the media or by hon. Members or globally there were some issues regarding them. This Committee is monitoring the adverse drug reactions whenever they occur. We have one very competent Drug Technical Advisory Board (DTAB). When a particular drug is banned in some other countries, whether it could be permitted here or not, this is the highest body which approves or disapproves a drug. Sir, some of the drugs, like you said about 76-77 drugs and formulations put together, are not permitted to be used in India, so-called banned in India. But some of these drugs are being used in other countries, including some developed countries in Europe. The issue of some common drugs called Analgen or Nimesulide, was raised last time very passionately by Mr. Bagrodia and my other good friend Shrimati Karat. I had taken up this issue of Nimesulide and other drugs with the authorities. In fact, a committee was formed under Dr. Gupta, the Head of Department, All-India Institute of Medical Sciences. Three of them went into the issue of Nimesulide and till today they have not found fault with it. But the study is still going on. The study has not ended here. In case of Nimesulide, we have gone through extensive deliberations right from 2000-01 when this was banned in Finland and Spain, and then it was revised. Today, about 50 countries, including a lot many countries in Europe, use Nimesulide. In India, Nimesulide drops are not permitted, but in paediatrics combination, we have a minimal dose of that.
My good friend has raised some questions about morphine combinations. I think we will try to look into this issue. As I said, the DTAB is a body which approves or disapproves some medicines, there are some medicines which could be used and there are some medicines which could be abused also. Sometimes the Home Ministry gives us some guidance like in the North-East part of the country some cases of common cough syrups abuse have come. The young kids in the North-East, in fact, injected a drug called Spasmo Proxyvon. It is not supposed to be injected. I will take up these things and put up them to my experts and we can find out about it.
About the decision of the Committee, yes, I can give the full report to the hon. Member about all the decisions of the Committee and how in future they will guide us and what should be done in future. In fact, Dr. Mashelkar, after taking sense of the Committee, has given his recommendations about the future of what could be done in the drug industry. On Dr. Mashelkar's recommendations, now we are on the verge of forming a National Drug Authority about which I have already informed this august House. It is on the lines of the FDA in America. Its building will be ready in a few months. I have moved a Cabinet note on the National Drug Authority. Once the authority comes into being, a lot more streamlining of the structure will be happening in this country on the positive ground.
Of course, about the structure of the DTAB, I will definitely inform the hon. Member, because I am not aware of it. But this is the highest body. The DTAB has the drug controllers of all the States. Such is its composition. They meet once a year or twice a year and deliberate upon the previously approved topics given by us. So, this is the highest body which has the Drug Commissioners or Drug Controllers of all the States. This is the composition. But about intricate composition, I will get back to him.
Coming to the Pharmaco-Vigilance Programme, this is the World Bank aided programme to strengthen our vigilance sector because in some drugs, there have been some adverse reactions which have not been reported. So, we are trying to form a network of not only of medical colleges, but also of doctors, pharmacists, and clinicians all put together. We want essential information about any adverse reaction not only of a new drug but of existing drugs also. We need to have more information about those reactions. (Contd. by VKK/4S)
DR. ANBUMANI RAMDOSS (CONTD.): For that also, we are trying to have more viable pharmaco-vigilance. We are spending more money on the structure also. And, of course, the protocol for pharmaco-vigilance has definitely been developed. I will again give the complete set of functions of the Pharmaco-Vigilance Committee and the protocol to be followed to the hon. Member. Coming to the last issue about animal hormones, we will definitely look into the issue. We have been getting some queries about the issue of how these things have been misused on animals, for example, Oxytocinfor excess milk production. Sir, we will definitely look into this.
Mr. Shreegopal Vyas is concerned about the Indian system of medicines and how Yoga could be used. Of course, we are trying to propagate Yoga in a big way. We are trying to put Yoga in the curriculum of the schools because it is scientifically proven that Yoga could prevent a lot of diseases, like it could reduce hypertension. It could prolong the occurrence of heart-attack. Although it can't prevent it fully, but it will prolong it. (Interruptions) I would be very happy. In fact, in this session, I was thinking, if I could have the health check-ups for the hon. Members, where I could have Yoga classes where Members of Parliament can come there. But, I am sure that in the Monsoon Session, we would be going for, at least, one week Yoga course where, in the morning or evening, hon. Members can come at their convenience, take part and learn the art of Yoga which is very, very important. In the schools, the memory power of children has increased; their grasping power has increased and the life style. So, all these things change. So, I think, it is very important that the hon. Member brought about this.
In fact, Sir, for DTAB, I think, I would like to differ. I have got some information about it, not all the drug controllers are members; it has got specific members specified in the Act. Some of them come as special invitees to the session. When I get the composition, I will give to the hon. Member. I would like to assure the hon. Members that the Government is definitely looking at the issue very, very closely. There has been a lot of competition in the market. Companies are vying with each other; there have been occupation problems within and the professional problems within the existing companies. There is the blame-game going on. We are very closely monitoring and definitely, we won't allow anything detrimental to the Indian society to happen at all. With these words, I would once again thank the hon. Member for raising this issue.
MR. DEPUTY CHAIRMAN: Only five minutes are left.
SHRI SANTOSH BAGRODIA: Half-an-hour is not yet over, Sir. We still have half-an-hour.
MR. DEPUTY CHAIRMAN: For half-an-hour, twenty-five minutes are over.
SHRI SANTOSH BAGRODIA: Sir, I think fifteen minutes are over. You please check from the records. If it is twenty-five minutes, we still have five minutes and I will take only one minute. It is for you also well, Sir. I am talking about it because the hon. Health Minister has mentioned about the health check-ups of MPs, I just want to draw your attention on this that the scheme of the health check-up of the MPs is very poor. As a result, the scheme is not successful. I would request him to follow the scheme of some hospitals like the Apollo Hospital etc. Look into that kind of scheme and have that kind of scheme. Otherwise, nobody goes there. I mean, the scheme is there, but if you go by the record, you will find that the scheme is not being followed. That is the only point and that will include you also.
MR. DEPUTY CHAIRMAN: Yes, everybody. I am very happy.
DR. ANBUMANI RAMDOSS: Sir, the suggestion is well taken. We will try to rectify if there are any issues. Last year, I think, a year before, we had the health check-ups for the hon. Members, where literally about 360 Members participated in one week -- not only health check-ups, but the awareness camp about Yoga, the Indian system of medicines, cancer and smoking, lot of things and the dietary exhibition. It was very, very useful. But, we could not have it last year. But this year, we are trying to plan it, and we will ask the hon. Members to keep fit, and follow all these patterns that will have a healthy lifestyle.
MR. DEPUTY CHAIRMAN: Keep fit to be present in the House.
DR. ANBUMANI RAMDOSS: Yes, Sir. s)
MR. DEPUTY CHAIRMAN: The Half-an-Hour discussion is over. Now, Special Mentions. wed by MKS/4t)
CAPTIVE USE BY KARNATAKA POWER COPORATION LIMITED
SHRIMATI PREMA CARIAPPA (KARNATAKA): Sir, my home-State, Karnataka, is facing a severe power shortage which has adversely affected the industrial sector, heavy, medium and small-scale industries, households, business establishments and all walks of life, including the students and housewives. The State Government of Karnataka, through Karnataka Power Corporation Ltd., (KPCL), is trying its best to increase the generation of power in the State. KPCL is going to implement the second unit of 500 MW for Bellary Thermal Power Station and the eighth unit of 210 MW for Raichur Thermal Power Station. For this, coal will be required in abundance. So, coal blocks are required by KPCL. This issue was taken up with the Ministry of Coal, which has indicated that coal linkage from Mahanadi Coalfields can be provided. However, this offer has two main shortcomings, namely, there is a shortage of coal at Mahanadi Coalfields, and, moreover, the cost of generation will become very high if the coal is supplied from Talchar as it will involve heavy transportation expenses. KPCL has identified Mahan Coal Block under South Eastern Coalfields Ltd. and has sought the Captive Coal Block allotment. In this connection, the hon. Chief Minister of Karnataka has even written to the hon. Prime Minister.
Hence, in order to increase the power generation in Karnataka, I request the hon. Minister of Coal to be generous enough in the best interest of Karnataka and allot Mahan Coal Block to the Karnataka Power Corporation Limited, on a priority basis, to solve the power crisis in Karnataka. Thank you, Sir. (Ends)
OF SIXTH CENTRAL PAY COMMISSION FOR CENTRAL
GOVERNMENT EMPLOYEES IN THE COUNTRY
SHRI O.T. LEPCHA (SIKKIM): Mr. Deputy Chairman, Sir, I would like to draw the attention of the Government regarding resentment and frustration among the Central Government employees over the non-setting up of the Sixth Central Pay Commission. This avoidable situation has developed due to the non-responsive attitude of the Central Government on this genuine issue.
Sir, the Fifth Central Pay Commission had, in the year 1997, recommended that there should be a permanent wage review body for reviewing and revising the wage structures of the Central Government employees periodically. The Fifth Central Pay Commission has also stated that if the Government is not able to set up a permanent wage review body, it should, at least, concede the right of the Central Government employees to have a complete pay revision once in ten years. The Commission had also stated that the Sixth Central Pay Commission be appointed by the year 2003 so that new pay scales for the Central Government employees could be made effective from 1.1.2006. In banking, insurance and other public sector enterprises, a wage revision has taken place after every four to five years. As the Government is aware that hundreds of anomalies in the pay scales have arisen consequent upon the implementation of the Fifth Pay Commission pay scales which are yet to be resolved, these anomalies can be solved by appointing a new Pay Commission. But it is a matter of grave concern that the Central Government has done nothing, and they are not serious over the setting of the Sixth Central Pay Commission.
I, therefore, urge upon the Government to appoint, immediately, the Sixth Central Pay Commission for reviewing and revising the wage structures of the Central Government employees. Thank you, Sir. (Ends)
SHRI MULE VENKATA MYSURA REDDY (ANDHRA PRADESH): Sir, cement is one of the key elements in creating infrastructure in the country. Of late, the prices of cement are going up without any rhyme or reason. In fact, in the last six months, the price-increase is up to 40 per cent, which is not justified at all. It is not that all of a sudden, the demand has surpassed the supply. Moreover, the price-rise is not due to the increase in the cost of inputs that go in the manufacture of cement. (Contd. by 4U)
SHRI MULE VENKATA MYSURA REDDY (CONTD.): But it is due to the fact that the major players have formed a cartel and on one pretext or the other they will stop production in the name of dispatch holiday or shut down the plants in the name of repairs. In this way, they create artificial scarcity in the market for limitless profiteering by pegging prices of cement.
As per newspaper reports the hon. Minister has held two meetings with the cement manufacturers and directed them to reduce this unreasonable hike in cement prices by 15th of this month. I do not know whether the cement manufacturers have paid any heed to the warning given by the Government. But there is no perceptible decline in the prices of cement at the market level.
Therefore, I request the hon. Minister of Commerce and Industry to take stern steps against cement manufacturers for hiking the prices of cement in an unjustified and unacceptable manner, and thus save the consumers from this unreasonable hike in cement prices. Thank you.
MR. DEPUTY CHAIRMAN: The House stands adjourned to meet at 11.00 A.M. tomorrow.
The House then adjourned at twenty-one minutes past seven
of the clock till eleven of the clock on Friday, the 19th May, 2006.